UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine? Author's reply

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (4), p.534-535

Ferlitsch, A.

2018

Volltextzugriff (PDF)

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Volltextzugriff (PDF)

Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1329-1330

2018

Volltextzugriff (PDF)

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.86-94

2018

Volltextzugriff (PDF)

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.139-149

2017

Volltextzugriff (PDF)

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1162-1169

2018

Volltextzugriff (PDF)

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply

Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1537-1538

2018

Volltextzugriff (PDF)

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.451-459

2018

Volltextzugriff (PDF)

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.83-91

2012

Volltextzugriff (PDF)

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.707-718

2015

Volltextzugriff (PDF)

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.966-979

2018

Volltextzugriff (PDF)

Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double‐blind, placebo‐controlled study

Alimentary pharmacology & therapeutics, 2004-08, Vol.20 (4), p.437-443

2004

Volltextzugriff (PDF)

Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005-01, Vol.21 (1), p.49-55

2005

Volltextzugriff (PDF)

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV―hepatitis C virus coinfected patients

AIDS (London), 2013-01, Vol.27 (2), p.227-232

2013

Volltextzugriff (PDF)

Letter: sorafenib in portal hypertension - authors' reply

Alimentary pharmacology & therapeutics, 2012-11, Vol.36 (10), p.994-995

2012

Volltextzugriff (PDF)

Short- and long-term effects of therapy with interferon-a and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005, Vol.21 (1), p.49-55

2005

Volltextzugriff (PDF)

Predictive value of CK-MB test

Circulation (New York, N.Y.), 1981-02, Vol.63 (2), p.467-468

1981

Volltextzugriff (PDF)

The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test

PloS one, 2016-02, Vol.11 (2), p.e0149230-e0149230

2016

Volltextzugriff (PDF)

Sedation in Screening Colonoscopy: Impact on Quality Indicators And Complications

The American journal of gastroenterology, 2012-12, Vol.107 (12), p.1837-1848

2012

Volltextzugriff (PDF)

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

The American journal of gastroenterology, 2021-04, Vol.116 (4), p.723-732

2021

Volltextzugriff (PDF)

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

Hepatology (Baltimore, Md.), 2012-10, Vol.56 (4), p.1439-1447

2012

Volltextzugriff (PDF)

Impact of Bowel Preparation Quality on Colonoscopy Findings and Colorectal Cancer Deaths in a Nation-Wide Colorectal Cancer Screening Program

The American journal of gastroenterology, 2024-10, Vol.119 (10), p.2036-2044

2024

Volltextzugriff (PDF)

Response to Shaikh et al

The American journal of gastroenterology, 2013-05, Vol.108 (5), p.853-854

2013

Volltextzugriff (PDF)

Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2014-02, Vol.39 (3), p.331-338

2014

Volltextzugriff (PDF)

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites

PloS one, 2014-11, Vol.9 (11), p.e110503

2014

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

SpracheKoreanisch

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Humans
(29)
Life Sciences & Biomedicine
(27)
Female
(23)
Gastroenterology & Hepatology
(22)
Male
(21)
Middle Aged
(20)
Pharmacology & Pharmacy
(15)
Adult
(14)
Aged
(13)
Cirrhosis
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Liver Cirrhosis
(9)
Mortality
(9)
Gastroenterology
(8)
Hypertension
(8)
Liver Diseases
(8)
Retrospective Studies
(8)
Gastroenterology. Liver. Pancreas. Abdomen
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine? Author's reply

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double‐blind, placebo‐controlled study

Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV―hepatitis C virus coinfected patients

Letter: sorafenib in portal hypertension - authors' reply

Short- and long-term effects of therapy with interferon-a and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Predictive value of CK-MB test

The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test

Sedation in Screening Colonoscopy: Impact on Quality Indicators And Complications

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

Impact of Bowel Preparation Quality on Colonoscopy Findings and Colorectal Cancer Deaths in a Nation-Wide Colorectal Cancer Screening Program

Response to Shaikh et al

Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites

Aktive Filter

Suchergebnisse filtern